Canada markets close in 5 hours 33 minutes

Inventiva S.A. (IVA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.0600+0.3100 (+8.27%)
As of 10:09AM EST. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    Inventiva announces a new Director of the Board of Directors

    Daix (France), Long Island City (New York, United States), November 21, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of nonalcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announces that, effective on November 9th, 2022, Inventiva’s board of directors coopted Dr. Lucy Lu as the Director of its Board of Directors in lieu of S

  • GlobeNewswire

    Inventiva reports 2022 Third Quarter Financial Information¹

    Cash position2 at €72.6m as of September 30, 2022, not including the $12.6 million upfront payment received from Sino Biopharm on November 4, 2022Revenues of €0.1m for the first nine months of 2022 Daix (France), Long Island City (New York, United States), November 10, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepat

  • Zacks

    Take the Zacks Approach to Beat the Market: Caterpillar, Amgen, Inventiva in Focus

    Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.